To promote, coordinate and support activities in the areas of clinical and translational research (CI&T) and biomedical innovation, contributing to the optimization of Portugal’s clinical, scientific and technological potential.


AICIB aims to be a national and European reference as an entity capable of creating the essential conditions to stimulate clinical research and biomedical innovation in Portugal.


To Carry out activities of national interest in financing and promoting IC&T and biomedical innovation through support for its development and internationalization.

Streamline R&D activities and cooperation between health care units, other health institutions (DGS, IPS, ACSS, SPMS, INSA, among others), scientific and academic institutions, and the various stakeholders involved in the process. The aim is to synergistically stimulate their potential, increasing value for society, patients, the health system and the training of health professionals in IC&T.

To Promote a scientific culture and the creation of economic value in the area of health, ensuring its sustainability and the adoption of best practices established nationally and internationally.

Constitution /
Organisation Chart


General Assembly


Paula Alves


Paula Macedo


Carlos Lima Alves
Audit Committee


Emília Alves


Miguel Andrade

Certified public accountant

João Careca
Management Board


Catarina Resende Oliveira


Nuno Sousa

Member of the Board

Anabela Isidro

Member of the Board

Heitor Costa

Member of the Board

João Cerqueira

Advisory Board


Helena Canhão


Luis Taborda-Barata

Other Members

AICIB’s Constitution and By-Laws

Resolution of the Council of Ministers – Authorization for the constitution of AICIB – Agency for Clinical Research and Biomedical Innovation and the Statutes of AICIB are available for consultation in the Republic’s Diary.